Adagio Medical (ADGM) Stock Price, News & Analysis

Company Overview

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

Key Stats

• Today's Range: $3.81 to $4.35
• 50-Day Range: N/A
• 52-Week Range: $3.63 to $9.34
• Volume: 27,400 shs
• Average Volume: 45,813 shs
• Market Capitalization: $32.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ADGM Stock Analysis - Frequently Asked Questions

How have ADGM shares performed this year?

Adagio Medical's stock was trading at $5.10 at the beginning of the year. Since then, ADGM shares have decreased by 16.5% and is now trading at $4.26.
View the best growth stocks for 2024 here.

How do I buy shares of Adagio Medical?

Shares of ADGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/18/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ADGM
• CUSIP: N/A
• CIK: 2006986
• Web: adagiomedical.com
• Phone: (212) 284-2300
• Fax: N/A
• Employees: 85
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,130,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -12.35%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $266,000.00
• Price / Sales: 120.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($3.49) per share
• Price / Book: -1.22

Miscellaneous

• Outstanding Shares: 7,540,000
• Free Float: N/A
• Market Cap: $32.12 million
• Optionable: N/A
• Beta: -0.03